|
Alzheimer's Disease Prevention Trial Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified medical advice, visits or professional assistance with a genuine dr.. We are not doctors. Always consult your mD about Alzheimer's Disease Prevention Trial conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Alzheimer's Disease Prevention Trial Clinical research trials and Alzheimer's Disease Prevention Trial medical trials take place in many of places throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new does drugs. The purpose of the studies / projects is to solve specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to find cures for all varieties of conditions, like Alzheimer's Disease Prevention Trial. Alzheimer's Disease Prevention Trial Clinical Trials and other clinical trials allow for volunteers to have health treatment options before they are available to the masses. Many times the human subjects acquire professional assistance for free of charge, and sometimes they are compensated for their time. Occasionally there is a cost for a Alzheimer's Disease Prevention Trial clinical trial. Test subjects typically obtain the finest healthcare available for their Alzheimer's Disease Prevention Trial condition. Dangers are a reality, nevertheless, and might include additional or frequent doctor trips, medical dangers (possibly life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > Alzheimer's Disease Prevention Trial  Alzheimer's Disease Prevention Trial
Alzheimer's Disease Prevention Trial
For Condition: Alzheimer Disease,Memory Disorders
Status: No longer recruiting
Sponsor(s): National Institute on Aging (NIA) ,
Synopsis: This is a three-year study to determine if estrogens can prevent memory loss and Alzheimer's disease in women with a family history of Alzheimer's disease.
Details: PREventing Postmenopausal memory loss and Alzheimer's with Replacement Estrogens (PREPARE) is a double-blind-placebo controlled trial to determine whether estrogen (or estrogen and progesterone) can delay the onset of memory loss or Alzheimer's Disease in elderly women with a family history of the disease.
Eligibility:
Study Type: Interventional, Prevention, Randomized, Double-Blind, Placebo Control
Minimum Age/Maximum Age: 65 Years/
Genders: Female
Protocol Entry Criteria: Inclusion Criteria: - Healthy women 65 or older with a family history of memory problems not currently on estrogen. Exclusion Criteria: - Significant neurological impairment - Current estrogen use - History of breast cancer
Total Enrollment:
Location and Contact Information:
Overall Study Official:
MarySano, Principal Investigator, Mount Sinai Medical Center
University of Alabama
Birmingham, Alabama, 35294
United States
Lee Memorial Health System
Ft. Myers, Florida, 33901
United States
St. Mary's Medical Center
West Palm Beach, Florida, 33407
United States
Medical University of South Carolina
North Charleston, South Carolina, 29406
United States
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, 21224
United States
Cornell Medical Center, New York Presbyterian Medical Center
New York City, New York,
United States
New England Center for Headache
Stamford, Connecticut, 06902-1249
United States
Neurology Group of Bergen County
Ridgewood, New Jersey, 07450
United States
Butler Hospital, Rhode Island Hospital
Providence, Rhode Island, 02906
United States
Howard University
Washington D.C., District of Columbia, 20060
United States
Mayo Clinic Jacksonville
Jacksonville, Florida, 32225
United States
North Broward Medical Center
Pompano Beach, Florida,
United States
Tallahassee Memorial Health Center
Tallahassee, Florida, 32308
United States
Burke Medical Research Institute
White Plains, New York, 10605
United States
Columbia University
New York City, New York, 10032
United States
West Florida Regional Medical Center
Pensacola, Florida, 32514
United States
Eastern Virginia Medical School
Norfolk, Virginia, 23507-1912
United States
University of California, Irvine
Irvine, California, 29697-4540
United States
New York United Hospital Medical Center
Port Chester, New York, 10573
United States
Clinical Pharmaceutical Trials
Tulsa, Oklahoma, 74104-5428
United States
Duke University Medical Center
Durham, North Carolina, 27710
United States
Wein Center
Miami, Florida, 33140
United States
Additional Information:
Study ID Numbers: IA0018; RO 1AG15922-01
Study Start Date:
Record last reviewed: October 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000176
Other Alzheimer Disease Studies:
1. Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study
2. Multicenter Trial of Prednisone in Alzheimer's Disease
3. Brain Imaging in Alzheimer's Disease
4. Serotonergic Pharmacotherapy for Agitation of Dementia
5. Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
Related Studies:
Other Alzheimer Disease Clinical Trials
Other New Jersey Clinical Trials
Other Ridgewood Clinical Trials
Alzheimer's Disease Prevention Trial
|
|
|
|
|
|
|
|
